Connect with us

COVID-19

CDC Quietly Admits to Covid Policy Failures

Published

7 minute read

From the Brownstone Institute

BY Harvey RischHARVEY RISCH 

Instead of admitting policy error that the Covid vaccines do not much control virus spread, our public health administration doubled down, attempting then to compel vaccination on as many more people as could be threatened by mandates.

In so many words—and data—CDC has quietly admitted that all of the indignities of the Covid-19 pandemic management have failed: the masks, the distancing, the lockdowns, the closures, and especially the vaccines; all of it failed to control the pandemic.

It’s not like we didn’t know that all this was going to fail, because we said so as events unfolded early on in 2020, that the public health management of this respiratory virus was almost completely opposite to principles that had been well established through the influenza period, in 2006. The spread of a new virus with replication factor R0 of about 3, with more than one million cases across the country by April 2020, with no potentially virus-sterilizing vaccine in sight for at least several months, almost certainly made this infection eventually endemic and universal.

Covid-19 starts as an annoying, intense, uncomfortable flu-like illness, and for most people, ends uneventfully 2-3 weeks later. Thus, management of the Covid-19 pandemic should not have relied upon counts of cases or infections, but on numbers of deaths, numbers of people hospitalized or with serious long-term outcomes of the infection, and of serious health, economic, and psychological damages caused by the actions and policies made in response to the pandemic, in that order of decreasing priorities.

Even though numbers of Covid cases correlate with these severe manifestations, that is not a justification for case numbers to be used as the actionable measure, because Covid-19 infection mortality is estimated to range below 0.1% in the mean across all ages, and post-infection immunity provides a public good in protecting people from severe reinfection outcomes for the great majority who do not get serious “long-Covid” on first infection.

Nevertheless, once the Covid-19 vaccines were rolled out, with a new large wave of the Delta strain spreading across the US in July-August 2021 even after eight months of the vaccines taken by half of Americans, instead of admitting policy error that the Covid vaccines do not much control virus spread, our public health administration doubled down, attempting then to compel vaccination on as many more people as could be threatened by mandates. That didn’t work out too well as seen when the large Omicron wave hit the country during December 2021-January 2022 in spite of some 10% more of the population getting vaccinated from September through December of 2021.

A typical mandate example: in September 2021, Washington Governor Jay Inslee issued Emergency Proclamation 21-14.2, requiring Covid-19 vaccination for various groups of state workers. In the proclamation, the stated goal was, “WHEREAS, COVID-19 vaccines are effective in reducing infection and serious disease, and widespread vaccination is the primary means we have as a state to protect everyone…from COVID-19 infections.” That is, the stated goal was to reduce the number of infections.

What the CDC recently reported (see chart below), however, is that by the end of 2023, cumulatively, at least 87% of Americans had anti-nucleocapsid antibodies to and thus had been infected with SARS-CoV-2, this in spite of the mammoth, protracted and booster-repeated vaccination campaign that led to about 90% of Americans taking the shots. My argument is that by making policies based on number of infections a higher priority than ones based on the more serious but less common consequences of both infections and policy damages, the proclaimed goal of the vaccine mandate to reduce spread failed in that 87% of Americans eventually became infected anyway.

In reality, neither vaccine immunity nor post-infection immunity were ever able fully to control the spread of the infection. On August 11, 2022, the CDC stated, “Receipt of a primary series alone, in the absence of being up to date with vaccination* through receipt of all recommended booster doses, provides minimal protection against infection and transmission (3,6). Being up to date with vaccination provides a transient period of increased protection against infection and transmission after the most recent dose, although protection can wane over time.” Public health pandemic measures that “wane over time” are very unlikely to be useful for control of infection spread, at least without very frequent and impractical revaccinations every few months.

Nevertheless, infection spread per se is not of consequence, because count of infections is not and should not have been the main priority of public health pandemic management. Rather, the consequences of the spread and the negative consequences of the policies invoked should have been the priorities. Our public health agencies chose to prioritize a failed policy of reducing the spread rather than reducing the mortality or the lockdown and school and business closure harms, which led to unnecessary and avoidable damage to millions of lives. We deserved better from our public health institutions.

Republished from the author’s Substack

Author

  • Harvey Risch

    Harvey Risch, Senior Scholar at Brownstone Institute, is a physician and a Professor Emeritus of Epidemiology at Yale School of Public Health and Yale School of Medicine. His main research interests are in cancer etiology, prevention and early diagnosis, and in epidemiologic methods.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

NIH Quietly Altered Definition For Gain-Of-Function Research On Its Website, Former Fauci Aide Confirms

Published on

From the Daily Caller News Foundation

By JASON COHEN

 

National Institutes of Health (NIH) Principal Deputy Director Lawrence Tabak confirmed on Thursday that his agency’s communications department altered NIH’s definition for gain-of-function research, with the change being “vetted” by “experts.”

The NIH until Oct. 20, 2021 defined this research as “modif[ying] a biological agent so that it confers new or enhanced activity to that agent,” while “some scientists use the term broadly to refer to any such modification,” according to the House Oversight Committee. Republican Rep. Nicole Malliotakis of New York questioned Tabak, a former aide to Dr. Anthony Fauci, about the agency changing its definition of the research on its website, asking him who authorized the alteration.

WATCH:

The current website does not define gain-of-function research, but asserts this research is usually uninvolved with enhanced potential pandemic pathogens.

“The change was made by our communications department because of the confusion that people have about the generic term of gain-of-function and the specific term gain-of-function,” Tabak testified.

Malliotakis responded by suggesting the communications department would not be qualified to make a change like this and must have had other input.

“The content was vetted,” Tabak testified. “By individuals who are subject-matter experts.”

Fauci firmly denied that the National Institute of Allergy and Infectious Diseases (NIAID) funded gain-of-function research on bat-based coronaviruses at the Wuhan Institute of Virology (WIV) before the COVID-19 pandemic during a Senate hearing in May 2021.

“The NIH has not ever and does not now fund gain of function research in the Wuhan Institute of Virology,” Fauci said.

Tabak testified on Thursday that the NIH did fund this research at the Wuhan Institute of Virology, but it “depends on [the] definition.”

The NIAID, which Fauci previously led, funded the nonprofit group EcoHealth Alliance to study bat-based coronaviruses in China that consisted of the transfer of $600,000 to the WIV, the Daily Caller News Foundation previously reported.

Continue Reading

COVID-19

COVID Lab Leak: Over four later, EcoHealth Alliance funding is finally suspended

Published on

From Heartland Daily News

Thursday, May 16, 2024

Federal Funding Stripped From Nonprofit at Center of COVID Lab Leak Controversy

Today, the Biden administration suspended federal funding to the scientific nonprofit whose research is at the center of credible theories that the COVID-19 pandemic was started via a lab leak at the Wuhan Institute of Virology.

This morning, the U.S. Department of Health and Human Services (HHS) announced that it was immediately suspending three grants provided to the New York-based nonprofit EcoHealth Alliance (EHA) as it starts the process of debarring the organization from receiving any federal funds.

“The immediate suspension of [EcoHealth Alliance] is necessary to protect the public interest and due to a cause of so serious or compelling a nature that it affects EHA’s present responsibility,” wrote HHS Deputy Secretary for Acquisitions Henrietta Brisbon in a memorandum signed this morning.

For years now, EcoHealth has generated immense controversy for its use of federal grant money to support gain-of-function research on bat coronaviruses at the Wuhan lab.

In a memo justifying its funding suspension, HHS said that EcoHealth had failed to properly monitor the work it was supporting at Wuhan. It also failed to properly report on the results of experiments showing that the hybrid viruses it was creating there had an improved ability to infect human cells.

Congressional Republicans leading an investigation into EcoHealth’s research in Wuhan, and the role it may have played in starting the pandemic via a lab leak, cheered HHS’s decision.

“EcoHealth facilitated gain-of-function research in Wuhan, China without proper oversight, willingly violated multiple requirements of its multimillion-dollar National Institutes of Health [NIH] grant, and apparently made false statements to the NIH,” said Rep. Brad Wenstrup (R–Ohio), chair of the House’s Select Subcommittee on the Coronavirus Pandemic in a statement. “These actions are wholly abhorrent, indefensible, and must be addressed with swift action.”

Beginning in 2014, EcoHealth received a grant from NIH’s National Institute of Allergies and Infectious Diseases (NIAID) to study bat coronavirus in China. Its initial scope of work involved collecting and cataloging viruses in the wild and studying them in the lab to spot which ones might be primed to “spillover” into humans and cause a pandemic.

Soon enough, EcoHealth used some of the viruses they’d collected to create “chimeric” or hybrid viruses that might be better able to infect human lung cells in genetically engineered (humanized) mice.

This so-called “gain-of-function” research has long been controversial for its potential to create deadly pandemic pathogens. In 2014, the Obama administration paused federal funding of gain-of-function research that might turn SARS, MERS, or flu viruses into more transmissible respiratory diseases in mammals.

In 2016, NIH flagged EcoHealth’s work as likely violating the 2014 pause.

EcoHealth President Peter Daszak argued to NIH at the time that the viruses his outfit was creating had not been proven to infect human cells and were genetically different enough from past pandemic viruses that they didn’t fall under the Obama administration pause.

Wuhan Institute of Virology and Peter Daszak of EcoHealth Alliance

NIH accepted this argument under the condition that EcoHealth immediately stop its work and notify the agency if any of its hybrid viruses did show increased viral growth in humanized mice.

But when these hybrid viruses did show increased viral growth in mice, EcoHealth did not immediately stop work or notify NIH. It instead waited until it submitted an annual progress report in 2018 to disclose the results of its experiments.

A second progress report that EcoHealth submitted in 2021, two years after its due date, also showed its hybrid viruses were demonstrating increased viral growth and enhanced lethality in humanized mice.

In testimony to the House’s coronavirus subcommittee earlier this month, Daszak claimed that EcoHealth attempted to report the results of its gain-of-function experiments on time in 2019, but was frozen out of NIH’s reporting system.

The HHS memo released today says a forensic investigation found no evidence that EcoHealth was locked out of NIH’s reporting system. The department also said that EcoHealth had failed to produce requested lab notes and other materials from the Wuhan lab detailing the work being done there and the lab’s biosafety conditions.

These all amount to violations of EcoHealth’s grant agreement and NIH grant policy, thus warranting debarment from future federal funds, reads the HHS memo.

That EcoHealth would be stripped of its federal funding shouldn’t come as too great a shock to anyone who watched Daszak’s congressional testimony from earlier this month. Even Democrats on the committee openly accused Daszak of being misleading about EcoHealth’s work and manipulating facts.

Rep. Raul Ruiz (D–Calif.), the ranking Democrat on the House’s coronavirus subcommittee, welcomed EcoHealth’s suspension, saying in a press release that the nonprofit failed its “obligation to meet the utmost standards of transparency and accountability to the American public.”

An HHS Office of the Inspector General report from last year had already found that EcoHealth had failed to submit progress reports on time or effectively monitor its subgrantee, the Wuhan Institute of Virology.

When grilling Daszak, Democrats on the Coronavirus Subcommittee went to great lengths to not criticize NIH’s oversight of EcoHealth’s work. The HHS debarment memo likewise focuses only on EcoHealth’s failures to abide by NIH policy and its grant conditions.

Nevertheless, it seems pretty obvious that NIH was failing to abide by the 2014 pause on gain-of-function funding when it allowed EcoHealth to go ahead with creating hybrid coronaviruses under the condition that they stop if the viruses did prove more virulent.

NIH compounded that oversight failure by not stopping EcoHealth’s funding when the nonprofit did, in fact, create more virulent viruses, and not following up on a never-submitted progress report detailing more gain-of-function research until two years later.

The House Subcommittee’s investigation into NIH’s role in gain-of-function research at the Wuhan lab is ongoing. Tomorrow it will interview NIH Principal Deputy Director Lawerence Tabak. In June, it will interview former NIAID Director Anthony Fauci.

Originally published by Reason Foundation. Republished with permission.

Continue Reading

Trending

X